95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.17%
Negative revenue growth while FSM stands at 12.52%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
0.25%
Gross profit growth under 50% of FSM's 40.63%. Michael Burry would be concerned about a severe competitive disadvantage.
3.15%
EBIT growth below 50% of FSM's 718.85%. Michael Burry would suspect deeper competitive or cost structure issues.
3.15%
Operating income growth under 50% of FSM's 718.85%. Michael Burry would be concerned about deeper cost or sales issues.
2.06%
Net income growth under 50% of FSM's 346.23%. Michael Burry would suspect the firm is falling well behind a key competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.22%
Share reduction more than 1.5x FSM's 3.95%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.23%
Diluted share change of 0.23% while FSM is zero. Bruce Berkowitz might see a minor difference that could widen over time.
3.61%
Dividend growth of 3.61% while FSM is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-7.33%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-7.91%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
88.45%
10Y revenue/share CAGR at 50-75% of FSM's 144.01%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
31.69%
5Y revenue/share CAGR at 50-75% of FSM's 44.61%. Martin Whitman would worry about a lagging mid-term growth trajectory.
-14.86%
Negative 3Y CAGR while FSM stands at 4.91%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
42.03%
10Y OCF/share CAGR at 50-75% of FSM's 69.55%. Martin Whitman might fear a structural deficiency in operational efficiency.
16.03%
Below 50% of FSM's 50.82%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-25.58%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
16.64%
Below 50% of FSM's 959.13%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
23.39%
Below 50% of FSM's 26308.11%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
603.37%
3Y net income/share CAGR above 1.5x FSM's 244.25%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
136.18%
10Y equity/share CAGR at 50-75% of FSM's 226.61%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
21.55%
Below 50% of FSM's 84.75%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
6.29%
Below 50% of FSM's 32.15%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
64.38%
Dividend/share CAGR of 64.38% while FSM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
47.34%
3Y dividend/share CAGR of 47.34% while FSM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
17.16%
Our AR growth while FSM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
0.31%
Asset growth well under 50% of FSM's 7.41%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.16%
BV/share growth above 1.5x FSM's 0.17%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-13.66%
We’re deleveraging while FSM stands at 26.45%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
6.41%
SG&A declining or stable vs. FSM's 35.31%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.